Erode Pharma Private Limited
About Erode Pharma Private Limited
Data last updated:
Erode Pharma Private Limited is a private limited company based in Erode, Tamil Nadu, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 01 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U52310TZ2010PTC015793. Its GSTIN is 33AACCE3189K1ZI (Tamil Nadu).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sembagounder Kaligoundan (Whole-Time Director) and Sambasivam Sivananthan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Erode Trust Hospital Campus 42/14 Chinnamuthu II Street Natesar Mill Enclave Perundu, Rai Road, Tamil Nadu, India – 638001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹54.56 Lakh (net margin 24.5%) and EBITDA of ₹73.21 Lakh (EBITDA margin 32.9%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 17% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Erode Pharma Private Limited's registered office is in Erode, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressErode Trust Hospital Campus 42/14 Chinnamuthu II Street Natesar Mill Enclave Perundu, Rai Road, Tamil Nadu, India – 638001
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Erode Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Erode Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Erode Pharma Private Limited, buy the company report.
Financials of Erode Pharma Private Limited
FY 2025 filings availableErode Pharma Private Limited reported revenue of ₹2.22 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 13% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹73.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.9% | ||||
| Net Profit Margin | 24.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Erode Pharma Private Limited, buy the company report.
Board of directors of Erode Pharma Private Limited
Erode Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sembagounder Kaligoundan | Whole-Time Director | 01 Apr 2013 | 13 Years 7 Months | Current |
| Sambasivam Sivananthan | Whole-Time Director | 01 Apr 2013 | 13 Years 7 Months | Current |
| Kandasamy Subramanian Mahadevan | Director | 01 Feb 2010 | 16 Years 9 Months | Current |
| Senguttuvan Soundararajan Also directs: Saravana Chem Dyes LLP, The Ecotech Innovators LLP, Sri Paranjothi Institute of Natural Excellence Private Limited and 5 more | Director | 01 Feb 2010 | 16 Years 9 Months | Current |
| Muthukrishnan Sundaravadivu | Whole-Time Director | 20 Oct 2011 | 15 Years 0 Months | Current |
Peer comparison
Erode Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nano Image Diagnostics Private Limited | ₹2.24 Cr (FY 2025) | 118.0% | Satara, Maharashtra, India | |||
| Cutisinternational Cosmetic Clinics Private Limited | ₹2.23 Cr (FY 2024) | 125.0% | Kozhikode, Kerala, India | |||
| Arete Care Private Limited | ₹2.23 Cr (FY 2024) | 56.0% | Angul, Odisha, India | |||
| Animani Healthcare Private Limited | ₹2.23 Cr (FY 2025) | -33.0% | Bathinda, Punjab, India | |||
| Adwin Life Care Private Limited | ₹2.22 Cr (FY 2024) | 26.0% | Thane, Maharashtra, India | |||
| Erode Pharma Private Limitedthis company | ₹2.22 Cr (FY 2025) | ₹54.56 Lakh | 24.5% | -13.0% | 5 | Erode, Tamil Nadu, India |
| Vetscan Diagnostics Private Limited | ₹2.22 Cr (FY 2025) | 16.0% | Delhi, India | |||
| Atishay Super Specialist Hospital Private Limited | ₹2.21 Cr (FY 2025) | 33.0% | Indore, Madhya Pradesh, India | |||
| Saumerpith Nursing Pvt Ltd | ₹2.21 Cr (FY 2019) | -6.0% | Assam, India | |||
| Acne Care Clinics Private Limited | ₹2.21 Cr (FY 2025) | 16.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Erode Pharma Private Limited, buy the company report.
Auditor
Erode Pharma Private Limited is audited by JAYANTI ASHOK for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAYANTI ASHOK | FY 2017 | 001299S |
Shareholding
The shareholding of Erode Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Erode Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Erode Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erode Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Erode Pharma Private Limited has a workforce of 5 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Erode Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCE3189K1ZI | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Erode Pharma Private Limited, buy the company report.
Recent activity
Erode Pharma Private Limited has 9 board changes on record since 2010: 5 appointments and 4 cessations. The latest: Arumugam Manoharan ceased to be Whole-Time Director on 28 Dec 2018.
Frequently asked questions
Erode Pharma is an active private limited company based in Erode, Tamil Nadu, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 01 February 2010 (16+ years old) and is registered under CIN U52310TZ2010PTC015793.
Erode Pharma has 5 current directors:
- Sembagounder Kaligoundan - Whole-Time Director
- Sambasivam Sivananthan - Whole-Time Director
- Muthukrishnan Sundaravadivu - Whole-Time Director
- Kandasamy Subramanian Mahadevan - Director
- Senguttuvan Soundararajan - Director
The latest financial statements of Erode Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Erode Pharma is 33AACCE3189K1ZI, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Erode Pharma is U52310TZ2010PTC015793. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erode Pharma was incorporated on 01 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Erode Pharma by revenue are Nano Image Diagnostics Private Limited, Cutisinternational Cosmetic Clinics Private Limited, Arete Care Private Limited, Animani Healthcare Private Limited, Adwin Life Care Private Limited and 4 more, all in the same principal business activity (other hospital and medical care activities).
Arumugam Manoharan ceased to be Whole-Time Director on 28 Dec 2018. Pushpa Rangasamy ceased to be Director on 28 Dec 2018. Senthil Vidhyasagar Jagadeesan ceased to be Whole-Time Director on 15 Mar 2016. Erode Pharma has 9 board changes on record in total.
The registered office of Erode Pharma is at Erode Trust Hospital Campus 4214 Chinnamuthu II Street Natesar Mill Enclave Perundu, Rai Road, Tamil Nadu, India – 638001.
Erode Pharma operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Erode Pharma is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
